Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,1.16 [1.1-1.22],2.89955970533291e-08,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.26 [1.13-1.41],5.05165812291973e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.34 [1.15-1.55],0.000126267672244448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD302,CD302 antigen,Inverse variance weighted,9,0.8 [0.7-0.92],0.00130966799364084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRG2,Bone marrow proteoglycan,Wald ratio,1,2.19 [1.33-3.6],0.00208787318733403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.1 [1.03-1.17],0.00258868375680724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCN4,CCN family member 4,Inverse variance weighted,27,0.89 [0.82-0.96],0.00403261465053242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.92 [0.87-0.98],0.00591323046884237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KITLG,Kit ligand,Wald ratio,1,0.34 [0.15-0.74],0.00690477257718336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.57 [1.12-2.21],0.00870634039249057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD48,CD48 antigen,Inverse variance weighted,18,1.09 [1.02-1.16],0.00919255768348651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.53 [0.33-0.87],0.0108947303895953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.21 [1.04-1.41],0.0125928603781794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.96 [0.92-0.99],0.0154448976149854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.3 [1.05-1.61],0.0160482198946539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.81 [0.68-0.96],0.0168874996118646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLKB1,Plasma kallikrein,Inverse variance weighted,15,0.9 [0.82-0.98],0.0189385131948362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.1 [1.02-1.2],0.0193226852600585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.23 [1.03-1.46],0.0212440722746783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,0.78 [0.63-0.96],0.0219343777958448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.58 [0.36-0.93],0.0239361300103222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.93 [0.88-0.99],0.0253531217915166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,12,0.85 [0.73-0.98],0.0267753918833478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.76 [0.6-0.97],0.0277721631231065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.82 [0.68-0.98],0.0281648738310493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.16 [1.02-1.32],0.0283191163914172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.89 [0.8-0.99],0.0328522354198629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,2.2 [1.05-4.61],0.0371384695646167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.2 [1.01-1.43],0.0393623408647338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.15 [1-1.32],0.0439085110391834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.78 [0.61-0.99],0.0441201232806234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MILR1,Allergin-1,Inverse variance weighted,33,0.95 [0.91-1],0.0444781779061139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.13 [1-1.28],0.0458872202785627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.38 [1.01-1.9],0.0465030362975846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AMBP,Protein AMBP,Inverse variance weighted,3,1.37 [1-1.9],0.0518540966252011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.94 [0.87-1],0.0533082997619988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.9 [0.8-1],0.0541825639848188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PENK,Proenkephalin-A,Inverse variance weighted,19,1.1 [1-1.22],0.0566390905290323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.26 [0.99-1.59],0.0574300229033802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.67 [0.45-1.01],0.0584352888515782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.08 [1-1.17],0.0589532831445063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.09 [1-1.2],0.0599337229268788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.5 [0.98-2.3],0.0634672628363458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.77 [0.58-1.02],0.0660379989843041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.15 [0.99-1.34],0.0702749880863212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.72 [0.5-1.03],0.0749357428744767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.22 [0.98-1.51],0.0756936109597514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.13 [0.99-1.3],0.0773825834501244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.13 [0.99-1.3],0.0779323094484982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.28 [0.97-1.69],0.0780541921204176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,1.06 [0.99-1.12],0.0806503210638112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,1.14 [0.98-1.33],0.0817960400753418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.78 [0.88-8.79],0.0824883565652705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.86 [0.72-1.02],0.0826070688766442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.08 [0.99-1.17],0.0827683165787297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.84 [0.69-1.02],0.0828367956577091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.08 [0.99-1.18],0.0831925987108322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS9,Galectin-9,Inverse variance weighted,26,1.08 [0.99-1.19],0.084266874302491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.93 [0.85-1.01],0.0870445134715022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.77 [0.57-1.04],0.0900420001975671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,0.89 [0.77-1.02],0.0902203742618249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.58 [0.31-1.09],0.0912742311713433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.17 [0.97-1.41],0.095284883394012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AGRN,Agrin,Inverse variance weighted,17,0.9 [0.8-1.02],0.0975481786605637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,10,0.91 [0.81-1.02],0.0994377986828953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC3B,Tetranectin,Inverse variance weighted,7,0.86 [0.73-1.03],0.100055304694815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHAD,Chondroadherin,Inverse variance weighted,3,1.11 [0.98-1.27],0.10135742553138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.88 [0.75-1.03],0.101416567211655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.14 [0.97-1.34],0.103593829963634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS3,Galectin-3,Inverse variance weighted,25,0.94 [0.86-1.01],0.105761918368605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.12 [0.98-1.29],0.106224543783396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.91 [0.81-1.02],0.108565450194419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.89 [0.78-1.03],0.109714143672146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.35 [0.93-1.94],0.111818271617857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PVR,Poliovirus receptor,Inverse variance weighted,27,1.04 [0.99-1.1],0.118037060828058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.94 [0.87-1.02],0.119783757679305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCAN,Brevican core protein,Inverse variance weighted,3,1.14 [0.97-1.35],0.121578808751675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.11 [0.97-1.26],0.122866511860707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.09 [0.98-1.22],0.12310978493329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.1 [0.97-1.24],0.125089094708918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.08 [0.98-1.18],0.12784618061386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.94 [0.86-1.02],0.132922395042486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.82 [0.63-1.06],0.134770476833489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.87 [0.72-1.05],0.13792742852354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,0.92 [0.82-1.03],0.141191860374077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSTB,Cystatin-B,Inverse variance weighted,28,1.06 [0.98-1.15],0.146137024119504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LEG1,Protein LEG1 homolog,Inverse variance weighted,23,0.93 [0.85-1.03],0.15145131638114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SDC1,Syndecan-1,Inverse variance weighted,2,0.81 [0.61-1.08],0.156478709395436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.06 [0.98-1.14],0.156899393067305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.52 [0.84-2.73],0.162538140753499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.77 [0.53-1.11],0.16299713585926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.88 [0.74-1.05],0.16317778054427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.93 [0.85-1.03],0.164548152542162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA11,Serpin A11,Inverse variance weighted,31,1.04 [0.98-1.11],0.165822207910875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGF,Placenta growth factor,Inverse variance weighted,2,2.08 [0.74-5.85],0.166265058603726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.09 [0.96-1.24],0.167964257741213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.34 [0.88-2.03],0.168111209032881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.8 [0.58-1.1],0.176604053432263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.29 [0.89-1.86],0.180805157261141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPPK1,Epiplakin,Inverse variance weighted,33,1.04 [0.98-1.11],0.182098124598319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.21 [0.91-1.6],0.189543743211966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.48 [0.82-2.68],0.190098406703711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.05 [0.97-1.13],0.192530699938044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS4,Galectin-4,Inverse variance weighted,4,0.85 [0.66-1.09],0.194854693195132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.96 [0.91-1.02],0.196206723634517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.09 [0.96-1.24],0.19633773275256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.95 [0.88-1.03],0.199420300244814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNR,Tenascin-R,Inverse variance weighted,16,1.06 [0.97-1.17],0.200302748820845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.49 [0.81-2.73],0.201378883957061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.05 [0.97-1.14],0.203295380383449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.71 [0.42-1.21],0.207405542823005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,APOA2,Apolipoprotein A-II,Wald ratio,1,0.68 [0.37-1.24],0.209246267229725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.18 [0.91-1.54],0.209697255563712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GRN,Progranulin,Inverse variance weighted,7,1.09 [0.95-1.23],0.210580700873739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.17 [0.91-1.49],0.214881844588675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,1.73 [0.73-4.11],0.215931404817796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.04 [0.98-1.11],0.216565973909997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.93 [0.83-1.04],0.219973230372878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.2 [0.9-1.61],0.220226123190553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.1 [0.94-1.3],0.22025897584947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.87 [0.7-1.09],0.22516313714539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.9 [0.75-1.07],0.227402827538908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.96 [0.91-1.02],0.228521238077561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.18 [0.9-1.56],0.230405226132954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.94 [0.84-1.04],0.231589506349961,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.88 [0.71-1.09],0.23175553609199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RTBDN,Retbindin,Inverse variance weighted,3,0.87 [0.7-1.09],0.232295867030385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.83 [0.61-1.13],0.232953445387184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.07 [0.96-1.2],0.233536142333885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.54 [0.2-1.49],0.234365561003452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1.09 [0.95-1.26],0.235111517517441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.93 [0.65-5.75],0.236109913847171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LMNB2,Lamin-B2,Wald ratio,1,0.56 [0.21-1.48],0.240216116868629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.81 [0.57-1.15],0.241080087395065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.08 [0.95-1.24],0.242533310650917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.94 [0.85-1.04],0.243607669426083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.22 [0.87-1.7],0.246552642969503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.04 [0.97-1.11],0.246575833349004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.98 [0.93-1.02],0.250038231475147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.06 [0.96-1.18],0.250963159910877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.9 [0.75-1.08],0.259311069121996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGA4,Pepsin A-4,Inverse variance weighted,2,0.71 [0.38-1.29],0.260317018013762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.69 [0.66-4.28],0.272027503002407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NFASC,Neurofascin,Inverse variance weighted,15,0.95 [0.86-1.04],0.272868547507631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.09 [0.93-1.29],0.274492549145368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.3 [0.81-2.07],0.275414962878476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRSS8,Prostasin,Inverse variance weighted,5,0.85 [0.64-1.14],0.276309507588399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD276,CD276 antigen,Inverse variance weighted,20,1.04 [0.97-1.12],0.288889732301261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.92 [0.78-1.08],0.291157904150701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTN,Pleiotrophin,Inverse variance weighted,4,1.21 [0.85-1.73],0.291834187134865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.95 [0.86-1.05],0.296678351440781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [0.97-1.09],0.298464560694094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.9 [0.75-1.09],0.299148129984304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.92 [0.79-1.08],0.302160941938223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGMN,Legumain,Inverse variance weighted,12,0.95 [0.85-1.05],0.303154586328812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSF,Cathepsin F,Inverse variance weighted,10,0.9 [0.74-1.1],0.308827536492508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL15,Interleukin-15,Wald ratio,1,7.25 [0.16-334.73],0.311122986765237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.08 [0.93-1.26],0.312646409139229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHGB,Secretogranin-1,Inverse variance weighted,27,0.97 [0.91-1.03],0.317011137615944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.02 [0.98-1.06],0.318763971273087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.97 [0.9-1.03],0.320952019724358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.05 [0.95-1.16],0.321099279958633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.91 [0.76-1.1],0.322598469542604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.83 [0.56-1.21],0.322699348343997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PSAP,Prosaposin,Inverse variance weighted,5,0.91 [0.76-1.1],0.334310610819696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.04 [0.96-1.11],0.336292875125255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.38 [0.72-2.65],0.338134087752363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.06 [0.94-1.18],0.338307785935969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.94 [0.84-1.06],0.340347231469174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.97 [0.9-1.04],0.341402532254518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.8 [0.5-1.28],0.34816039192268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.04 [0.95-1.14],0.349533943659089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MVK,Mevalonate kinase,Inverse variance weighted,2,1.23 [0.8-1.89],0.35002144644201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.12 [0.88-1.42],0.350495214526346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.07 [0.93-1.24],0.359724044415639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PALM,Paralemmin-1,Inverse variance weighted,6,1.1 [0.9-1.34],0.360307009283791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.81 [0.52-1.27],0.36200040708408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.09 [0.91-1.31],0.36491368304602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.83 [0.56-1.24],0.365505276845811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.97 [0.92-1.03],0.365689880170863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.96 [0.87-1.05],0.367729934985131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.02 [0.97-1.07],0.368368230684652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,0.87 [0.65-1.18],0.368650962319662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.74 [0.39-1.42],0.368931471378662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.06 [0.93-1.21],0.369965386655691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.07 [0.92-1.24],0.374167019565971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.16 [0.84-1.59],0.374215300745976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,1.08 [0.91-1.3],0.377825877304342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.06 [0.93-1.21],0.378921356279783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.05 [0.94-1.16],0.382405922154167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.11 [0.88-1.41],0.382728150740332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.92 [0.75-1.12],0.384711433372296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCN3,CCN family member 3,Inverse variance weighted,19,1.05 [0.94-1.19],0.385325886356931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.96 [0.88-1.05],0.387316343963688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.21 [0.78-1.89],0.391469826288984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.05 [0.93-1.19],0.392078514314658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.16 [0.83-1.62],0.394027572423391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD46,Membrane cofactor protein,Wald ratio,1,0.82 [0.53-1.29],0.394528935078729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.97 [0.89-1.05],0.395895586064495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANXA10,Annexin A10,Wald ratio,1,0.72 [0.33-1.56],0.405009883497323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.11 [0.87-1.4],0.406070036645626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.87 [0.62-1.21],0.409099126323392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.06 [0.92-1.23],0.4117857371791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.09 [0.88-1.36],0.41225106621785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCAN,Neurocan core protein,Inverse variance weighted,3,0.9 [0.69-1.17],0.413264495198931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.98 [0.92-1.03],0.414023739960451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REN,Renin,Inverse variance weighted,4,1.06 [0.92-1.22],0.417590398650419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DSG2,Desmoglein-2,Inverse variance weighted,11,1.06 [0.93-1.2],0.4176240790299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.11 [0.86-1.44],0.419743125184108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.96 [0.86-1.06],0.423118887516389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.07 [0.91-1.25],0.429360552699982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.93 [0.78-1.11],0.431506363711323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD27,CD27 antigen,Inverse variance weighted,9,0.94 [0.82-1.09],0.432014047511891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.08 [0.9-1.29],0.432879306995206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.06 [0.91-1.23],0.433754865225957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VWC2,Brorin,Inverse variance weighted,22,1.04 [0.94-1.15],0.434328456617995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.05 [0.92-1.2],0.436995100282059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.92 [0.75-1.13],0.43905370290505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.94 [0.79-1.11],0.439383906772384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.92 [0.75-1.13],0.440595022167129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.3 [0.66-2.58],0.446861974786625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.02 [0.96-1.09],0.448807525573904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.91 [0.71-1.16],0.449476264368972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPON2,Spondin-2,Inverse variance weighted,4,1.08 [0.89-1.31],0.449571449105448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.03 [0.95-1.12],0.450618946707479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.95 [0.83-1.08],0.452969933180099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.95 [0.83-1.09],0.454313608880421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.9 [0.69-1.18],0.460010284214656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.04 [0.93-1.17],0.463238782989438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.96 [0.86-1.07],0.464300753706216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.95 [0.83-1.09],0.46537070575396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLK11,Kallikrein-11,Inverse variance weighted,6,1.04 [0.93-1.17],0.466978810800233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DSC2,Desmocollin-2,Inverse variance weighted,9,1.05 [0.92-1.2],0.469110724166626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.08 [0.87-1.35],0.475775742609757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.1 [0.84-1.45],0.477239672986509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.04 [0.93-1.17],0.478235508084331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.06 [0.9-1.24],0.478871388753565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.07 [0.88-1.3],0.481317712048593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MUC13,Mucin-13,Inverse variance weighted,9,0.94 [0.81-1.11],0.483702807239423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.19 [0.73-1.93],0.487262144603004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.13 [0.8-1.59],0.489288414447067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.04 [0.93-1.17],0.491003986457411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.06 [0.9-1.25],0.491264654564077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,0.96 [0.84-1.09],0.491542479896089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CFD,Complement factor D,Inverse variance weighted,11,0.96 [0.84-1.09],0.493314911197076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.94 [0.77-1.14],0.498517489346037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.96 [0.87-1.07],0.499250931393747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,30,1.03 [0.95-1.12],0.502375484125204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.98 [0.91-1.05],0.505625342659953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CES3,Carboxylesterase 3,Inverse variance weighted,7,0.95 [0.83-1.1],0.505745382314023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRTG,Protogenin,Inverse variance weighted,19,1.03 [0.95-1.12],0.506488005875731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.9 [0.66-1.22],0.506757070607945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.95 [0.8-1.12],0.510147942893238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.08 [0.85-1.38],0.515700277378465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.1 [0.82-1.47],0.518499732060454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.96 [0.84-1.09],0.518608109809664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.03 [0.95-1.11],0.52074302568953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.33 [0.55-3.23],0.527284922719791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.83 [0.47-1.47],0.528263016738527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.11 [0.8-1.54],0.532536285723757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.08 [0.86-1.35],0.533284120777704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.71 [0.24-2.1],0.533333241200007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.06 [0.89-1.26],0.534219960252088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.02 [0.96-1.07],0.538041187904075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.06 [0.88-1.28],0.539975871865614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDHR5,Cadherin-related family member 5,Inverse variance weighted,28,0.98 [0.91-1.05],0.540316773401703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.08 [0.84-1.4],0.547167287557803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.03 [0.94-1.11],0.54860579120944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1.08 [0.84-1.38],0.548623765761513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.05 [0.88-1.26],0.557196921201826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.32 [0.52-3.31],0.560641466686417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [0.96-1.08],0.561328996461038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.98 [0.91-1.05],0.56164501941999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.03 [0.94-1.12],0.56327906346964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.04 [0.92-1.17],0.567595258494273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.02 [0.95-1.1],0.567678969133877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.07 [0.85-1.35],0.569698492457924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.94-1.04],0.571437550162346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.92-1.05],0.57506077964029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.95 [0.79-1.14],0.585425430567168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.98 [0.9-1.07],0.593650576471596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.05 [0.87-1.26],0.59467472749674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.87 [0.53-1.45],0.600108572633271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HJV,Hemojuvelin,Wald ratio,1,0.94 [0.76-1.18],0.607067806306424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.89 [0.56-1.4],0.60886762862952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.94 [0.75-1.19],0.610365603870588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.04 [0.89-1.21],0.611657374106288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.97 [0.85-1.1],0.61276343183116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.9-1.06],0.612873509842284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.09 [0.78-1.52],0.615657496209725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.93 [0.7-1.24],0.617795029474752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PI3,Elafin,Inverse variance weighted,10,1.03 [0.92-1.16],0.619885037598167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.03 [0.9-1.18],0.622133469428223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.11 [0.72-1.71],0.625298131376991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.07 [0.81-1.41],0.628533259297446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AREG,Amphiregulin,Inverse variance weighted,3,0.94 [0.73-1.21],0.632288482824523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.01 [0.95-1.08],0.636284730522659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS1,Galectin-1,Inverse variance weighted,6,1.06 [0.84-1.33],0.638671096646554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBP2,Retinol-binding protein 2,Wald ratio,1,0.86 [0.44-1.65],0.639791733109815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.06 [0.82-1.38],0.640700873034967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.97 [0.87-1.09],0.643526872883269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1.04 [0.88-1.23],0.648150830167492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL32,Interleukin-32,Inverse variance weighted,11,0.97 [0.84-1.11],0.648886596466521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,0.97 [0.85-1.11],0.650737833094245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.02 [0.95-1.09],0.650798784490819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.8 [0.29-2.15],0.65364148382657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.98 [0.88-1.09],0.653665401678837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CNTN5,Contactin-5,Inverse variance weighted,28,0.99 [0.92-1.05],0.653669544984799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAYN,Layilin,Inverse variance weighted,20,1.03 [0.92-1.15],0.654364223606407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.94-1.11],0.65478715739822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.97 [0.85-1.11],0.655766418605984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD83,CD83 antigen,Inverse variance weighted,5,1.05 [0.86-1.28],0.662587203556532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.82-1.13],0.662751230343289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.96 [0.82-1.13],0.664958536407426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,C7,Complement component C7,Inverse variance weighted,38,0.99 [0.94-1.04],0.665763575274369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.95-1.08],0.668182547291009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SELENOP,Selenoprotein P,Inverse variance weighted,2,0.93 [0.66-1.3],0.66968078251164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.03 [0.91-1.15],0.673151233498744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.95-1.08],0.685431469105837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.01 [0.95-1.08],0.68563820616109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.95 [0.74-1.22],0.688533965327383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,1.04 [0.86-1.25],0.689828409826208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.99 [0.93-1.05],0.6919335290232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.03 [0.88-1.2],0.698961241627212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,0.98 [0.89-1.08],0.699420089983684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSL,Cathepsin L1,Wald ratio,1,1.18 [0.5-2.82],0.702778427851902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.05 [0.8-1.38],0.703323388004168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.99 [0.95-1.04],0.704711503334951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.03 [0.9-1.18],0.707044679983481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.9-1.16],0.708807376795435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,17,1.01 [0.94-1.09],0.710954413039309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.82 [0.29-2.32],0.712470962654274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCN15,Lipocalin-15,Inverse variance weighted,20,1.01 [0.95-1.08],0.713969389442447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.95 [0.74-1.23],0.715312294133109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NECTIN4,Nectin-4,Inverse variance weighted,7,0.98 [0.86-1.11],0.716097244901599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.95 [0.73-1.24],0.717716208512126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.84 [0.33-2.15],0.718947215251406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSLN,Mesothelin,Inverse variance weighted,25,1.01 [0.95-1.08],0.720037787518958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NECTIN2,Nectin-2,Inverse variance weighted,5,0.97 [0.85-1.12],0.720329086957538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,F11,Coagulation factor XI,Inverse variance weighted,19,1.03 [0.88-1.21],0.721098515229036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.97 [0.8-1.17],0.723587230498427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.88 [0.43-1.81],0.725222623621882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SEPTIN8,Septin-8,Inverse variance weighted,2,1.05 [0.79-1.39],0.728493616110402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.97 [0.79-1.18],0.729748452670375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA4,Kallistatin,Inverse variance weighted,26,1.01 [0.95-1.08],0.732059983942372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.95 [0.73-1.25],0.735238044483401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.98 [0.86-1.11],0.740069970415886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GSN,Gelsolin,Inverse variance weighted,5,1.05 [0.77-1.45],0.742069834945766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.02 [0.92-1.12],0.74884175643484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.01 [0.96-1.05],0.750291725682606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.99 [0.9-1.08],0.750892324235908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH6,Cadherin-6,Inverse variance weighted,29,1.02 [0.93-1.11],0.752653894595012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCG2,Secretogranin-2,Wald ratio,1,0.87 [0.38-2.03],0.752771301542381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RSPO1,R-spondin-1,Inverse variance weighted,5,1.03 [0.87-1.21],0.75535034164938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BSG,Basigin,Wald ratio,1,0.96 [0.72-1.28],0.758380712492842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCHE,Cholinesterase,Inverse variance weighted,30,0.99 [0.9-1.08],0.758602367367825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.04 [0.82-1.3],0.758724929047565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.95 [0.68-1.32],0.758876057438421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.99 [0.93-1.06],0.768151471964197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPON1,Spondin-1,Inverse variance weighted,21,0.99 [0.89-1.09],0.768268304349795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.98 [0.86-1.12],0.768573473951344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.06 [0.72-1.57],0.769644526604024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.03 [0.86-1.22],0.781650048239188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.96-1.06],0.783904143627909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.08 [0.62-1.89],0.78576333587572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.94 [0.6-1.47],0.786305646442994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.92 [0.49-1.71],0.787217195120019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.97 [0.78-1.21],0.787631153262412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.98 [0.86-1.12],0.789099621235541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.83-1.16],0.794666015828212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.01 [0.92-1.12],0.794794318190065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.97 [0.74-1.26],0.796662034974888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.05 [0.73-1.5],0.797713873362275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ELN,Elastin,Inverse variance weighted,2,1.07 [0.63-1.81],0.804428216356757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.97 [0.74-1.27],0.806955294576972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EDN1,Endothelin-1,Inverse variance weighted,3,1.03 [0.79-1.36],0.809576114977992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.02 [0.89-1.16],0.809798661036126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.02 [0.86-1.22],0.810110246846083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.97 [0.78-1.21],0.810250282170486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.98 [0.8-1.19],0.81444982521097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHGA,Chromogranin-A,Inverse variance weighted,3,1.05 [0.7-1.58],0.814675249491082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.96 [0.71-1.31],0.815280729955578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.98 [0.8-1.19],0.817920753925426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.95 [0.62-1.45],0.819496621511998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.99 [0.9-1.09],0.820537464034636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD70,CD70 antigen,Inverse variance weighted,28,1.01 [0.94-1.08],0.821684226965058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PALM2,Paralemmin-2,Inverse variance weighted,8,1.02 [0.87-1.2],0.821881217837751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TMSB10,Thymosin beta-10,Wald ratio,1,1.08 [0.55-2.14],0.823068431686337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.02 [0.86-1.21],0.827037042613574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.07 [0.57-2],0.82823118279607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.84-1.24],0.829942290779684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.98 [0.81-1.19],0.830725507358787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.03 [0.79-1.34],0.833207336112324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,1.02 [0.87-1.19],0.837126072276971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.97 [0.72-1.3],0.837312490856152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RSPO3,R-spondin-3,Inverse variance weighted,6,1.03 [0.79-1.34],0.83765402398512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.99 [0.9-1.09],0.841906183193672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.01 [0.94-1.07],0.849386301509516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.99 [0.94-1.05],0.851299718605446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OCLN,Occludin,Inverse variance weighted,2,1.03 [0.76-1.39],0.85345869661373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.98 [0.82-1.18],0.854466097914154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL18,Interleukin-18,Inverse variance weighted,16,1.02 [0.79-1.33],0.854653814346247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.94-1.05],0.85479590464841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.98 [0.76-1.25],0.856606634028332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD248,Endosialin,Inverse variance weighted,2,1.17 [0.21-6.61],0.859281470516776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.98 [0.8-1.2],0.863435359347673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.89-1.1],0.863502430162128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.01 [0.92-1.1],0.863738425930698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OGN,Mimecan,Inverse variance weighted,30,1.01 [0.92-1.11],0.864109996128293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.96 [0.62-1.49],0.864450925865505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.02 [0.85-1.22],0.869330424872415,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MDK,Midkine,Inverse variance weighted,4,1.02 [0.78-1.35],0.869446475063577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.94 [0.46-1.92],0.869569889226606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.88 [0.18-4.34],0.873615952780431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CST3,Cystatin-C,Inverse variance weighted,10,0.99 [0.85-1.15],0.875740432968629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.98 [0.7-1.36],0.882210492782045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRH,Corticoliberin,Inverse variance weighted,11,1.01 [0.91-1.12],0.883532708766917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PKD1,Polycystin-1,Inverse variance weighted,12,1.01 [0.86-1.19],0.886642108621825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.95-1.05],0.892385496115243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COLEC12,Collectin-12,Inverse variance weighted,11,1.01 [0.86-1.19],0.89270119534431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.02 [0.8-1.3],0.895395279183364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.03 [0.66-1.6],0.89710721653973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.99 [0.84-1.16],0.898601115505572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.01 [0.91-1.11],0.900556234616489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSO,Cathepsin O,Inverse variance weighted,6,0.98 [0.76-1.28],0.902933028656983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.89-1.11],0.902953299377625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.02 [0.79-1.31],0.905019550045214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.95-1.06],0.906813867789589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,1.01 [0.85-1.2],0.909005379280281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP1,Interstitial collagenase,Inverse variance weighted,31,1 [0.94-1.08],0.91012483035665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GUCA2A,Guanylin,Inverse variance weighted,9,0.99 [0.83-1.18],0.912913079103566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.98 [0.68-1.42],0.913960644717507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1 [0.91-1.09],0.917810239584924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.01 [0.88-1.15],0.921952233798044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.99 [0.81-1.21],0.92228862950492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.93-1.09],0.926956340585649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.97 [0.53-1.78],0.928596365006547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.99 [0.8-1.23],0.935130286740993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP7,Matrilysin,Inverse variance weighted,13,1 [0.9-1.11],0.94138021697511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.86-1.18],0.943580086835463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.98 [0.61-1.58],0.947085018701197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.01 [0.86-1.18],0.950283130064417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MB,Myoglobin,Wald ratio,1,0.97 [0.34-2.78],0.950549768153884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH1,Cadherin-1,Wald ratio,1,0.97 [0.41-2.29],0.952325423793072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.92-1.08],0.95444543378073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.99 [0.75-1.32],0.959205495380028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1 [0.9-1.12],0.961308314923671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADIPOQ,Adiponectin,Inverse variance weighted,13,1 [0.86-1.15],0.96495014254172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1 [0.9-1.11],0.965438730036295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH2,Cadherin-2,Inverse variance weighted,3,0.99 [0.66-1.49],0.966537242673642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD7,T-cell antigen CD7,Inverse variance weighted,8,1 [0.92-1.09],0.968592782475761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GHR,Growth hormone receptor,Inverse variance weighted,38,1 [0.96-1.05],0.969595816147151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLIN3,Perilipin-3,Wald ratio,1,0.99 [0.57-1.72],0.973130667079491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP10,Stromelysin-2,Inverse variance weighted,22,1 [0.91-1.1],0.978232751727657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.99 [0.62-1.59],0.983059131284855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.82-1.22],0.985392402360061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.87-1.15],0.987554189278965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SNCG,Gamma-synuclein,Inverse variance weighted,36,1 [0.93-1.07],0.988944551812973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1 [0.89-1.13],0.991990640653981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.96-1.05],0.994670858163503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.91-1.1],0.998551495541845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP7,Matrilysin,Wald ratio,1,0.44 [0.31-0.64],1.14494293874715e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.3 [1.11-1.52],0.00108510714502299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.51 [0.33-0.78],0.0019315849634392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.84 [1.22-2.76],0.00349265385512611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AMBP,Protein AMBP,Inverse variance weighted,5,1.4 [1.11-1.76],0.00454166567219973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GRN,Progranulin,Inverse variance weighted,46,1.1 [1.03-1.18],0.00552298562281363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.84 [0.75-0.95],0.00562576284742411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE6,Ribonuclease K6,Inverse variance weighted,4,2.05 [1.22-3.43],0.00672157877724106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.34 [1.08-1.66],0.00901625667232445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.78 [0.65-0.94],0.00980846598573672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.59 [0.4-0.88],0.00991841873746208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.91 [0.85-0.98],0.0126657736454294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.44 [1.08-1.92],0.0135385237377145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,3.02 [1.23-7.41],0.0160638557905943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CST3,Cystatin-C,Inverse variance weighted,3,2.27 [1.15-4.48],0.0180280079395858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PENK,Proenkephalin-A,Inverse variance weighted,15,1.21 [1.03-1.41],0.0182670533430527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,3.21 [1.22-8.48],0.0183667660139374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.26 [1.04-1.53],0.0185094606652796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.32 [1.03-1.69],0.0267273710793001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.37 [0.15-0.91],0.0305911586166346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,C7,Complement component C7,Inverse variance weighted,26,1.1 [1.01-1.21],0.0346186540970545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.37 [1.01-1.86],0.0397326307521581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.22 [1.01-1.49],0.0430770883182298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.09 [1-1.18],0.0446966147964717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.31 [1.01-1.7],0.044909857281597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MDK,Midkine,Inverse variance weighted,14,1.24 [1-1.53],0.0465037742424175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.81 [0.65-1],0.0497889318489575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.55 [1-2.4],0.0508898449161832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCAN,Neurocan core protein,Inverse variance weighted,19,0.85 [0.71-1.01],0.0592125207084964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.62 [0.38-1.02],0.0596833937173011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.36 [0.98-1.88],0.0622963983653975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.19 [0.99-1.42],0.0649494770505471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MILR1,Allergin-1,Inverse variance weighted,43,0.96 [0.92-1],0.071771201539624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.47 [0.2-1.08],0.075034002201317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.91 [0.83-1.01],0.0774607724489701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.7 [0.47-1.04],0.0794453118730638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.29 [0.97-1.71],0.0826878592822927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.64 [0.39-1.06],0.0841515889890982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.87 [0.75-1.02],0.0845749700329494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.06 [0.99-1.14],0.0902109902648605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.58 [0.31-1.09],0.090722978127788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSTB,Cystatin-B,Inverse variance weighted,23,1.07 [0.99-1.16],0.0920116123541654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.37 [0.95-1.97],0.0939631683606565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PSAP,Prosaposin,Inverse variance weighted,13,0.9 [0.79-1.02],0.0958127343525736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.81 [0.63-1.04],0.0961422744377724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCN4,CCN family member 4,Inverse variance weighted,29,0.92 [0.83-1.02],0.0962841139099416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.27 [0.96-1.7],0.0983141107872397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.61 [0.91-2.88],0.103960546710792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.75 [0.53-1.06],0.104466183791983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.92 [0.83-1.02],0.106169516415888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.87 [0.74-1.03],0.107125317383003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.29 [0.95-1.77],0.107345841171959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.81 [0.62-1.05],0.110798938750368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.63 [0.89-2.97],0.111067464490864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PVR,Poliovirus receptor,Inverse variance weighted,3,0.64 [0.37-1.11],0.112242166458306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,1.29 [0.94-1.76],0.113262764933928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.86 [0.71-1.04],0.113848386117937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.6 [0.31-1.15],0.121470641526549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.37 [0.92-2.04],0.122694347549202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.16 [0.96-1.41],0.122765715598585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.53 [0.89-2.61],0.123210451063086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WNT9A,Protein Wnt-9a,Wald ratio,1,2.36 [0.77-7.22],0.131627358598228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.87 [0.72-1.04],0.132008217019361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.92 [0.82-1.03],0.132017435951505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,0.92 [0.83-1.03],0.132202965845441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.3 [0.92-1.85],0.134025078248777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.94 [0.86-1.02],0.136023640776811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.13 [0.96-1.32],0.137880258065721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RTBDN,Retbindin,Inverse variance weighted,2,1.49 [0.88-2.52],0.139404329573108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.07 [0.98-1.16],0.139501652758471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.94 [0.87-1.02],0.140775655436131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.85 [0.69-1.06],0.145223259211949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.21 [0.94-1.55],0.147528025268513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.74 [0.49-1.12],0.151817855418609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,0.83 [0.64-1.07],0.152831221495905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS9,Galectin-9,Inverse variance weighted,36,1.07 [0.97-1.17],0.155344526510258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.84 [0.66-1.07],0.158337763210963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.37 [0.88-2.12],0.158989920181116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.12 [0.96-1.32],0.160264800243883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.55 [0.84-2.86],0.164957281564423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.91 [0.79-1.05],0.178859799631233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.93 [0.84-1.04],0.184389881902805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.28 [0.88-1.86],0.194000767522421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.07 [0.97-1.18],0.198099308203336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.07 [0.96-1.19],0.201569468309846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.89 [0.75-1.06],0.20375360909786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.79 [0.55-1.14],0.205500012315725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GHR,Growth hormone receptor,Inverse variance weighted,26,0.9 [0.77-1.06],0.207414422775639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.22 [0.9-1.66],0.207498591215778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.66 [0.75-3.65],0.20785044332198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.21 [0.9-1.62],0.208455978471512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.3 [0.86-1.96],0.209869299927824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.11 [0.94-1.32],0.210691562494897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.95 [0.88-1.03],0.212594081391201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.8 [0.56-1.14],0.213548199550046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BSG,Basigin,Inverse variance weighted,6,0.81 [0.57-1.14],0.221289056157518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.95 [0.87-1.03],0.22261494121219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.11 [0.94-1.32],0.227831616970986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.73 [0.71-4.23],0.231374248577842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.23 [0.87-1.74],0.233436196466015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.83 [0.62-1.13],0.236022233934303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.29 [0.85-1.96],0.237222539426688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD83,CD83 antigen,Inverse variance weighted,14,0.88 [0.72-1.09],0.241838206150182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.84 [0.63-1.13],0.243084509987011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CFP,Properdin,Inverse variance weighted,17,0.9 [0.75-1.08],0.244030798054105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.08 [0.95-1.23],0.246456194521533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.88 [0.7-1.1],0.247345326167772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REN,Renin,Inverse variance weighted,8,1.22 [0.87-1.69],0.249015402024108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRSS8,Prostasin,Inverse variance weighted,14,0.88 [0.7-1.1],0.249604442100456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.07 [0.95-1.2],0.25040077797032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.71 [0.68-4.27],0.250966469334225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.09 [0.94-1.26],0.253932397684613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.94 [0.84-1.05],0.265285464714234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.24 [0.85-1.79],0.265304032431225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.08 [0.94-1.24],0.270883868764394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.09 [0.94-1.27],0.271533028134578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OMD,Osteomodulin,Inverse variance weighted,15,1.09 [0.94-1.26],0.272847334933484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.68 [0.34-1.35],0.273383963277929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.05 [0.96-1.15],0.276668946344199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.06 [0.95-1.18],0.276968955351964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,0.86 [0.65-1.13],0.277280369915142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.88 [0.7-1.11],0.282775601520486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.96 [0.9-1.03],0.283984392456739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,0.91 [0.76-1.08],0.284211759574405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HJV,Hemojuvelin,Inverse variance weighted,2,1.45 [0.73-2.85],0.286988959311915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.13 [0.9-1.42],0.289590218080946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PKD1,Polycystin-1,Inverse variance weighted,12,1.16 [0.88-1.54],0.290748894365362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GUCA2A,Guanylin,Inverse variance weighted,7,0.83 [0.59-1.18],0.295504423014872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.28 [0.8-2.05],0.298290890452792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD70,CD70 antigen,Inverse variance weighted,11,1.15 [0.88-1.51],0.299681884462075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,POF1B,Protein POF1B,Inverse variance weighted,4,0.83 [0.59-1.18],0.302169571067426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.96 [0.9-1.03],0.302978957147296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGF,Placenta growth factor,Inverse variance weighted,5,0.85 [0.61-1.16],0.30440030692246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.95 [0.86-1.05],0.305735322476749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.09 [0.92-1.3],0.305784939617809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.85 [0.61-1.17],0.306744291604909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS4,Galectin-4,Inverse variance weighted,15,0.94 [0.84-1.06],0.307502569611054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MB,Myoglobin,Inverse variance weighted,9,0.88 [0.68-1.13],0.30911891586586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,1.09 [0.93-1.28],0.309779493897249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.53 [0.67-3.51],0.312705816587937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.06 [0.94-1.2],0.312714694652518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SEPTIN8,Septin-8,Inverse variance weighted,4,1.21 [0.83-1.77],0.312739904554549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.48 [0.69-3.21],0.314655558860233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.07 [0.93-1.23],0.31467723027203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTN,Pleiotrophin,Inverse variance weighted,3,1.25 [0.81-1.91],0.315986659447158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.28 [0.79-2.06],0.316639198042532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.93 [0.8-1.07],0.316640226214986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGA4,Pepsin A-4,Inverse variance weighted,7,0.84 [0.59-1.18],0.317112986208422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.13 [0.89-1.44],0.317658891938158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.84 [0.6-1.18],0.319505348534633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.74 [0.41-1.35],0.321948085303952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSL,Cathepsin L1,Inverse variance weighted,29,0.93 [0.8-1.08],0.336989394100007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.38 [0.72-2.65],0.338134087752363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.86 [0.62-1.18],0.338741209249189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.03 [0.97-1.1],0.339199063079415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.93 [0.79-1.09],0.345390958732891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.1 [0.9-1.33],0.347109477759249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.13 [0.88-1.44],0.348492226871556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.12 [0.88-1.43],0.350595246313661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.24 [0.79-1.93],0.351266922565533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.97-1.09],0.352593030336804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VWC2,Brorin,Inverse variance weighted,12,1.15 [0.85-1.57],0.354570624202062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.04 [0.96-1.12],0.364480461834839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRTG,Protogenin,Inverse variance weighted,8,0.85 [0.6-1.2],0.364590840869413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.9 [0.73-1.13],0.366002561281092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.37 [0.69-2.72],0.366588241141933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,1.59 [0.58-4.36],0.368831233384585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.09 [0.9-1.31],0.369455245277412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.73 [0.52-5.68],0.36987803164246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.14 [0.86-1.5],0.370516451916537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.66 [0.27-1.63],0.373137291507432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.25 [0.76-2.05],0.380182493563258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.87 [0.64-1.19],0.381904154924002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.67 [0.28-1.63],0.382942694829718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.88 [0.67-1.17],0.383246515516563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.79 [0.46-1.36],0.38858851757486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSLN,Mesothelin,Inverse variance weighted,11,1.1 [0.88-1.37],0.391496222373855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.83 [0.55-1.26],0.392726143398573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.91 [0.72-1.14],0.394770118645918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.93 [0.78-1.1],0.395585540382972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DSG2,Desmoglein-2,Inverse variance weighted,22,0.94 [0.82-1.08],0.397695033287239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.22 [0.76-1.97],0.404839482351017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.24 [0.75-2.07],0.406885980491423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.79 [0.44-1.39],0.409225214096348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.4 [0.63-3.13],0.410411875010352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.74 [0.37-1.51],0.410821767520708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.1 [0.87-1.4],0.411829236770817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.13 [0.84-1.53],0.41682753615819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.66 [0.24-1.8],0.417465276583281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CES3,Carboxylesterase 3,Inverse variance weighted,17,1.07 [0.91-1.25],0.428090415759272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.92 [0.75-1.13],0.429987636871059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.15 [0.81-1.62],0.430409982791913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH1,Cadherin-1,Inverse variance weighted,16,0.94 [0.82-1.09],0.432136254313981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.9 [0.69-1.18],0.432196768604657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.13 [0.82-1.55],0.442926064205139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NECTIN4,Nectin-4,Inverse variance weighted,4,1.24 [0.72-2.14],0.444392067349889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.11 [0.84-1.46],0.449368468917266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.86 [0.59-1.27],0.44942458582239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.13 [0.83-1.54],0.450204790189479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.12 [0.84-1.49],0.450944552333847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,F11,Coagulation factor XI,Inverse variance weighted,22,1.06 [0.92-1.21],0.452451797806948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.05 [0.93-1.18],0.453163483566297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHAD,Chondroadherin,Inverse variance weighted,15,1.05 [0.93-1.18],0.454509001136721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD302,CD302 antigen,Inverse variance weighted,11,1.09 [0.87-1.35],0.454571196797512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRH,Corticoliberin,Inverse variance weighted,55,1.03 [0.95-1.12],0.454607844314915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.21 [0.74-1.98],0.456640993767787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LEG1,Protein LEG1 homolog,Inverse variance weighted,34,1.03 [0.95-1.12],0.458578405358205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.78 [0.41-1.5],0.458812775614644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LMNB2,Lamin-B2,Inverse variance weighted,8,1.15 [0.8-1.65],0.46090777226965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.12 [0.83-1.52],0.462860120016585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SELENOP,Selenoprotein P,Inverse variance weighted,3,1.24 [0.69-2.23],0.46408194183982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.84-1.09],0.465528897725032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.15 [0.79-1.68],0.465943073365496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL32,Interleukin-32,Inverse variance weighted,9,1.09 [0.86-1.38],0.466767267558262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RSPO3,R-spondin-3,Inverse variance weighted,5,0.88 [0.63-1.24],0.467077559289838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.89 [0.66-1.21],0.46784279821279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,13,1.08 [0.88-1.33],0.470054280413105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AGRN,Agrin,Inverse variance weighted,14,0.92 [0.74-1.15],0.473460837660095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.25 [0.68-2.3],0.473778301103166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.05 [0.93-1.18],0.474083672104973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.95 [0.83-1.09],0.476153677830656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.1 [0.85-1.42],0.477972284205751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.08 [0.88-1.32],0.482600363073533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.94 [0.8-1.11],0.485872119906652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.12 [0.81-1.56],0.488981927861936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.07 [0.88-1.3],0.489850975661001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.92 [0.72-1.17],0.49146051000876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.87 [0.58-1.31],0.493712952635022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCN15,Lipocalin-15,Inverse variance weighted,22,0.98 [0.92-1.04],0.494004130410706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.85 [0.53-1.36],0.495400024983903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA4,Kallistatin,Inverse variance weighted,7,0.84 [0.51-1.39],0.500731289377545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.1 [0.84-1.44],0.500817605921111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.92-1.18],0.500990324746055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.76 [0.33-1.72],0.504555362923983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.11 [0.82-1.5],0.505760608752249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PALM,Paralemmin-1,Inverse variance weighted,4,0.87 [0.57-1.32],0.5073336842116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.11 [0.81-1.52],0.513133046481929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CNTN5,Contactin-5,Inverse variance weighted,22,0.95 [0.81-1.11],0.514525456987902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.93 [0.75-1.16],0.516028481936989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.78 [0.36-1.69],0.521335876420825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.06 [0.89-1.25],0.52273568823124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AREG,Amphiregulin,Inverse variance weighted,5,0.89 [0.62-1.27],0.525589867626808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,0.96 [0.84-1.1],0.530013309216744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.1 [0.81-1.49],0.532377819431157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.08 [0.86-1.35],0.533284120777704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSO,Cathepsin O,Inverse variance weighted,19,0.96 [0.86-1.08],0.534415408639489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.61 [0.12-2.98],0.538621898117832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL22,Interleukin-22,Inverse variance weighted,4,0.83 [0.46-1.5],0.53879105259362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSF,Cathepsin F,Inverse variance weighted,27,0.96 [0.84-1.09],0.540454186326039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1.07 [0.85-1.35],0.541015924834847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGLN1,Egl nine homolog 1,Wald ratio,1,1.33 [0.52-3.39],0.547476560217342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.05 [0.89-1.26],0.54974977237179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.08 [0.84-1.38],0.551703784446746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.31 [0.54-3.18],0.552584911012483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.24 [0.61-2.49],0.554974505979601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SERPINA11,Serpin A11,Inverse variance weighted,14,1.08 [0.83-1.42],0.557975636790774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PI3,Elafin,Inverse variance weighted,18,1.04 [0.91-1.19],0.560647627295917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.9 [0.61-1.31],0.567338681476924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.15 [0.71-1.85],0.567941856816665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP1,Interstitial collagenase,Inverse variance weighted,14,0.94 [0.75-1.17],0.568208026479557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.89 [0.61-1.32],0.570170888254196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.92 [0.71-1.21],0.570627019236568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.13 [0.74-1.73],0.571580414049841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.12 [0.76-1.63],0.571811751649188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.03 [0.92-1.15],0.572873297338166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.87 [0.53-1.42],0.573604455883049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.76 [0.29-2],0.576232382038598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.1 [0.79-1.52],0.581500571738708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.09 [0.81-1.46],0.582758354607668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.24 [0.57-2.71],0.584109367380586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.21 [0.62-2.37],0.584637188138704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD48,CD48 antigen,Inverse variance weighted,14,1.07 [0.84-1.36],0.588248761899557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.93 [0.69-1.23],0.597019529823656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,UMOD,Uromodulin,Inverse variance weighted,34,1.05 [0.88-1.26],0.597619686755057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MVK,Mevalonate kinase,Wald ratio,1,0.59 [0.08-4.23],0.598053345684536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.96 [0.84-1.11],0.59839740293941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.93 [0.7-1.23],0.60033659432759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.22 [0.58-2.55],0.602385966856548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.07 [0.84-1.36],0.602962650529213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.19 [0.61-2.34],0.60360322772465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.95 [0.79-1.15],0.606423744320168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.06 [0.84-1.34],0.611509440105602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.14 [0.7-1.85],0.611634537333831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPPK1,Epiplakin,Inverse variance weighted,30,1.02 [0.95-1.09],0.617240146931052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.04 [0.9-1.19],0.624349382432477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCG2,Secretogranin-2,Inverse variance weighted,2,1.3 [0.45-3.72],0.625080837878923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NRP1,Neuropilin-1,Inverse variance weighted,14,0.94 [0.73-1.21],0.625977541687552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.95 [0.78-1.16],0.629443891978289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAYN,Layilin,Inverse variance weighted,3,1.26 [0.49-3.24],0.629843411428224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.95 [0.76-1.18],0.630418813573084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.17 [0.62-2.2],0.630701706353433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.07 [0.82-1.4],0.631523070475508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.09 [0.78-1.52],0.631938196425457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.11 [0.72-1.74],0.632229037185378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.95 [0.79-1.16],0.637845239592446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.96 [0.81-1.14],0.642059413928291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,1.18 [0.58-2.4],0.643249731603299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KITLG,Kit ligand,Inverse variance weighted,30,1.03 [0.91-1.17],0.643798560545164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.98 [0.92-1.05],0.64570294368629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.05 [0.86-1.28],0.649130115105226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.02 [0.94-1.11],0.650143754318163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL19,Interleukin-19,Inverse variance weighted,10,0.97 [0.87-1.09],0.650469721033159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.17 [0.59-2.33],0.65274348857185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.13 [0.66-1.94],0.655366029448372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.92 [0.65-1.31],0.656656340779936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RSPO1,R-spondin-1,Inverse variance weighted,8,0.95 [0.76-1.19],0.659368524870196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CFD,Complement factor D,Wald ratio,1,1.2 [0.52-2.79],0.663590313207549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCHE,Cholinesterase,Inverse variance weighted,38,0.98 [0.88-1.09],0.664318912330001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.14 [0.61-2.14],0.672116015298121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,27,0.97 [0.84-1.12],0.67349350488949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHGB,Secretogranin-1,Inverse variance weighted,7,1.05 [0.83-1.33],0.674070647925639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MUC13,Mucin-13,Inverse variance weighted,3,0.85 [0.41-1.79],0.674702660562408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.97 [0.83-1.13],0.676021990059747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.03 [0.88-1.21],0.676602897717079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.04 [0.85-1.28],0.680797213049644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.03 [0.91-1.16],0.681404323117579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH6,Cadherin-6,Inverse variance weighted,5,1.09 [0.73-1.61],0.683216687446136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.04 [0.87-1.24],0.683459974819313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.06 [0.79-1.42],0.684392064104685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.88 [0.47-1.64],0.684949735484166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.08 [0.74-1.57],0.685268652028062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.23 [0.45-3.41],0.686881665361395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.79 [0.24-2.53],0.688460408279389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,1.04 [0.86-1.26],0.690003935696371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.08 [0.73-1.59],0.690430254955799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,1.01 [0.95-1.08],0.691152327400326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.18 [0.51-2.74],0.6919413287932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.99 [0.93-1.05],0.697277344444821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.03 [0.89-1.19],0.704791188351634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GSN,Gelsolin,Inverse variance weighted,7,0.95 [0.72-1.25],0.705763087140201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OGN,Mimecan,Inverse variance weighted,37,0.98 [0.89-1.08],0.705942909321781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.93 [0.66-1.33],0.707520739058475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.08 [0.72-1.63],0.708112702710288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLK11,Kallikrein-11,Inverse variance weighted,13,0.96 [0.79-1.18],0.708415805126622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.83-1.32],0.711600066956996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.08 [0.72-1.6],0.712036805191981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.1 [0.67-1.78],0.712659822174943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNR,Tenascin-R,Inverse variance weighted,19,0.97 [0.85-1.12],0.713766475482592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL18,Interleukin-18,Inverse variance weighted,26,1.02 [0.92-1.13],0.714673046493003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.91 [0.56-1.49],0.715079402773336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.99 [0.92-1.06],0.717014008290041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SDC1,Syndecan-1,Inverse variance weighted,12,0.96 [0.77-1.2],0.718253068429421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.98 [0.88-1.09],0.720400250846305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.05 [0.81-1.35],0.720982847153829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.06 [0.78-1.43],0.721613195088296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.94 [0.69-1.3],0.726290636298693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDH2,Cadherin-2,Inverse variance weighted,21,1.03 [0.88-1.19],0.727677981588448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.96 [0.76-1.21],0.729026594141956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.97 [0.8-1.17],0.729778154100484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.11 [0.61-2.04],0.729878994918005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.06 [0.74-1.53],0.733786099514121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.98 [0.9-1.08],0.73844534193089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.95-1.08],0.742044550661224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.05 [0.79-1.4],0.742765361039788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GAST,Gastrin,Inverse variance weighted,9,0.96 [0.75-1.22],0.743663887209499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGALS3,Galectin-3,Inverse variance weighted,15,1.03 [0.86-1.24],0.751478046423372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.97 [0.82-1.16],0.753136132107845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.1 [0.62-1.96],0.753487944695144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,1.03 [0.86-1.24],0.756043991336298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.96-1.03],0.75621006232817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.02 [0.88-1.2],0.756759111237185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.04 [0.83-1.3],0.757316455101602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LGMN,Legumain,Inverse variance weighted,22,0.97 [0.78-1.2],0.758213798816774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.04 [0.79-1.38],0.760816609856716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.91 [0.49-1.68],0.762749872854138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.97 [0.81-1.17],0.765703569095132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.98 [0.88-1.1],0.766137059680156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.95 [0.68-1.33],0.770134017491704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD248,Endosialin,Inverse variance weighted,17,0.97 [0.81-1.17],0.770308438042719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.94 [0.63-1.41],0.77111030087192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,0.97 [0.81-1.17],0.771387507865705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.04 [0.82-1.31],0.771857112024922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.93 [0.58-1.5],0.773983083837357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD27,CD27 antigen,Inverse variance weighted,9,1.05 [0.73-1.52],0.778403861057873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.97 [0.79-1.2],0.780272756956649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.04 [0.78-1.4],0.78165519380139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.04 [0.8-1.35],0.782685611904508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.1 [0.57-2.1],0.78396795680289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.03 [0.86-1.23],0.784949544002434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPON1,Spondin-1,Inverse variance weighted,4,0.91 [0.46-1.81],0.787287891426808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.03 [0.83-1.29],0.793424599950265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.96 [0.7-1.32],0.795111299661035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.04 [0.79-1.36],0.799038713164912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.98 [0.87-1.11],0.805969837658625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.89 [0.33-2.35],0.80749145788606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.09 [0.53-2.26],0.813843075409262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.96 [0.68-1.36],0.815632251934703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.09 [0.52-2.3],0.817079342852051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.08 [0.56-2.06],0.822380991689147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.97 [0.72-1.31],0.826551361254772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC3B,Tetranectin,Inverse variance weighted,2,1.08 [0.53-2.22],0.82975877930756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLKB1,Plasma kallikrein,Inverse variance weighted,20,0.98 [0.84-1.15],0.831743171173569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.04 [0.71-1.52],0.832088805588817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.99 [0.93-1.06],0.837462829985317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.04 [0.74-1.45],0.837827163849129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.04 [0.68-1.6],0.839251855203188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.01 [0.94-1.08],0.840339495649679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.97 [0.7-1.34],0.846042036840331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.98 [0.8-1.21],0.84691293012399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.9 [0.32-2.57],0.848567028258515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.91 [0.35-2.38],0.849545497060542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.03 [0.78-1.35],0.849890897964477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.04 [0.69-1.56],0.850042221581256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.03 [0.76-1.4],0.85044304062746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.96 [0.66-1.41],0.851496461093938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ELN,Elastin,Inverse variance weighted,10,0.97 [0.69-1.36],0.85247703709801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.02 [0.8-1.3],0.853233739054046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.03 [0.76-1.39],0.853713331108274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.95 [0.57-1.59],0.853802875939806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,COLEC12,Collectin-12,Inverse variance weighted,3,0.94 [0.45-1.93],0.859528111803003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.95 [0.52-1.74],0.860460519633138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.04 [0.7-1.54],0.861848937253501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.88-1.11],0.862961887511701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.03 [0.74-1.43],0.866435415338336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.03 [0.73-1.45],0.868036925480927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.1 [0.36-3.32],0.868777607919737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NFASC,Neurofascin,Inverse variance weighted,6,1.05 [0.58-1.92],0.871058114517787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.98 [0.76-1.26],0.872817210992963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.99 [0.88-1.11],0.873263309636212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MMP10,Stromelysin-2,Wald ratio,1,0.92 [0.34-2.52],0.873595541121727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.01 [0.87-1.18],0.875145512263703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,0.99 [0.82-1.18],0.877089067886296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.98 [0.8-1.21],0.879341248824719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,BCAN,Brevican core protein,Inverse variance weighted,12,0.98 [0.78-1.24],0.883254911174386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL6,Interleukin-6,Inverse variance weighted,6,0.99 [0.81-1.2],0.883601621467408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.02 [0.78-1.34],0.883699000833085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.01 [0.9-1.14],0.883727945039701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.04 [0.63-1.72],0.884939121848763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,KLK4,Kallikrein-4,Inverse variance weighted,5,1.04 [0.58-1.87],0.89146727335655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.99 [0.84-1.16],0.892031529680659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.91-1.08],0.89346488437212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.98 [0.77-1.26],0.893838593312965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.98 [0.73-1.32],0.893994964337138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DSC2,Desmocollin-2,Inverse variance weighted,16,0.99 [0.88-1.12],0.896186604371848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.98 [0.76-1.27],0.896257797695273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.01 [0.88-1.16],0.89680283207239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.02 [0.76-1.37],0.898976037491992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.99 [0.91-1.09],0.899606428169478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1.01 [0.88-1.16],0.900098578766654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.99 [0.82-1.19],0.900252216663463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.98 [0.68-1.41],0.901756207636616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.99 [0.88-1.12],0.902837621502416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,1.02 [0.74-1.4],0.903704988745615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.01 [0.88-1.15],0.912056288031542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.01 [0.85-1.19],0.921230209985977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CD99,CD99 antigen,Inverse variance weighted,4,1.02 [0.73-1.41],0.923836778616922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.94-1.05],0.926292775007248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,6,1.02 [0.67-1.56],0.926634268284946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.01 [0.74-1.39],0.927134453305528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.01 [0.86-1.18],0.928542924810273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.9-1.12],0.941143723984061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.91-1.09],0.9432979218174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,NECTIN2,Nectin-2,Inverse variance weighted,3,0.97 [0.44-2.15],0.945860664808627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.01 [0.77-1.32],0.946267380548069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.01 [0.68-1.52],0.946313248603838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.99 [0.83-1.19],0.949588634178831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.02 [0.61-1.7],0.949722280647751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SPON2,Spondin-2,Inverse variance weighted,3,1.03 [0.43-2.48],0.950754119826343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PALM2,Paralemmin-2,Inverse variance weighted,9,0.99 [0.84-1.17],0.952471740741523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.99 [0.72-1.37],0.952690246788788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.01 [0.83-1.22],0.953008365385228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.99 [0.66-1.47],0.956483407673724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.64-1.59],0.959400017925032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CDHR5,Cadherin-related family member 5,Inverse variance weighted,16,1 [0.85-1.17],0.961210834645753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1 [0.93-1.08],0.962160291079487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.99 [0.71-1.38],0.963643192605429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.99 [0.69-1.42],0.967522173977634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CHGA,Chromogranin-A,Inverse variance weighted,5,1.01 [0.68-1.48],0.971264022159942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1 [0.9-1.12],0.971771260675349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.01 [0.68-1.48],0.975718773239342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.01 [0.66-1.52],0.981005647434391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,OCLN,Occludin,Inverse variance weighted,2,0.99 [0.57-1.73],0.983312978135843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,GOLM2,Protein GOLM2,Inverse variance weighted,14,1 [0.86-1.17],0.987554790012338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1 [0.7-1.43],0.99549634386723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.81-1.23],0.996003677790081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1 [0.68-1.47],0.996934765581657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,1 [0.64-1.56],0.998982446565794,trans
